Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CaDIS: Cataract dataset for surgical RGB-image segmentation.

Medical image analysis·2021
Same author

Can surgical simulation be used to train detection and classification of neural networks?

Healthcare technology letters·2017
Same author

Development and Evaluation of a Novel Pan-Specialty Virtual Reality Surgical Simulator for Smartphones.

Studies in health technology and informatics·2016
Same author

Safety of transvaginal hybrid NOTES cholecystectomy: a systematic review and meta-analysis.

Surgical endoscopy·2014
Same author

Enhanced recovery simulation in colorectal surgery: design of virtual online patients.

Surgical endoscopy·2014
Same author

The role of the posterior parietal cortex in stereopsis and hand-eye coordination during motor task behaviours.

Cognitive processing·2014

Related Experiment Video

Updated: Feb 21, 2026

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

2.1K

Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart

Andre Chow1, Daniel J Stuckey2, Emaddin Kidher1

  • 1Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.

Stem Cell Reports
|October 10, 2017
PubMed
Summary
This summary is machine-generated.

Tissue engineering using polyethylene glycol hydrogel (PEG), stem cell-derived cardiomyocytes (iPSC-CMs), and erythropoietin (EPO) improved cardiac function after heart attack. This therapy enhanced heart thickness and muscle content, even without sustained cell engraftment.

Keywords:
MRIerythropoietinhydrogeliPSC-CMsinduced pluripotent stem cell-derived cardiomyocytesmyocardial infarctionmyocardial tissue engineeringrat

More Related Videos

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.9K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Related Experiment Videos

Last Updated: Feb 21, 2026

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

2.1K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.9K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cardiovascular Research

Background:

  • Myocardial infarction (MI) leads to significant cardiac damage and functional decline.
  • Current treatments for MI have limitations in fully restoring cardiac function.
  • Tissue engineering presents a promising avenue for cardiac repair.

Purpose of the Study:

  • To evaluate the efficacy of combined polyethylene glycol hydrogel (PEG), human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM), and erythropoietin (EPO) therapy in a rat model of myocardial infarction.
  • To assess the impact of this combination therapy on cardiac function and ventricular remodeling.
  • To investigate the role of cell engraftment in therapeutic outcomes.

Main Methods:

  • Induction of myocardial infarction in a rat model.
  • Injection of therapeutic agents including PEG hydrogel, iPSC-CMs, and EPO into infarcted hearts.
  • Assessment of cardiac function, chamber volumes, and ejection fraction over 10 weeks.
  • Histological analysis to evaluate infarct thickness and presence of grafted cells.

Main Results:

  • All treatment groups showed limited acute elevations in chamber volumes.
  • PEG-containing treatments attenuated ventricular remodeling after 10 weeks.
  • Significant increases in ejection fraction were observed in groups receiving gel-EPO, iPSC-CMs, or gel-iPSC-CM-EPO.
  • Increased infarct thickness and presence of muscle tissue within scars were noted across treatment groups.
  • No sustained donor-cell engraftment was detected.

Conclusions:

  • iPSC-CM-encapsulating bioactive hydrogel therapy, combined with EPO, significantly improves cardiac function post-myocardial infarction.
  • The therapy enhances infarct thickness and muscle content, suggesting beneficial effects on cardiac repair mechanisms.
  • Therapeutic benefits can be achieved even in the absence of sustained donor-cell engraftment, highlighting the potential of the biomaterial and EPO components.